These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 4892828)
1. [Clinical studies on the effect of Dezacetylolanatozide C (Polfa) in the treatment of heart diseases]. Wolański I; Grzywa M; Fijalkowska A Przegl Lek; 1969 Apr; 25(4):377-9. PubMed ID: 4892828 [No Abstract] [Full Text] [Related]
3. [Rational use of cardiac glycosides in certain diseases in childhood]. Sidel'nikov VM; Afanas'ev EN; Liutkevich VF Pediatr Akus Ginekol; 1975; (3):3-6. PubMed ID: 1230764 [No Abstract] [Full Text] [Related]
4. [Beta-acetyldigoxin and glycoside tolerance--clinical experiences]. Schröer W; Gerhard K Landarzt; 1968 Mar; 44(9):425-34. PubMed ID: 5718780 [No Abstract] [Full Text] [Related]
5. [Long-term study with the novel cardiac glycoside meproscillarin (author's transl)]. Eckardt A; Koch W; Safer A Arzneimittelforschung; 1978; 28(3a):570-3. PubMed ID: 348206 [TBL] [Abstract][Full Text] [Related]
6. [On the clinical trial of a heart and coronary drug]. Eisel K; Kaiser H Ther Ggw; 1968 Feb; 107(2):231-2 passim. PubMed ID: 5718464 [No Abstract] [Full Text] [Related]
7. [Clinical evaluation of Proscillaridin A, a glycoside of Scilla maritima]. Kedra M; Kedrowa S Pol Tyg Lek; 1968 May; 23(19):714-6. PubMed ID: 4876207 [No Abstract] [Full Text] [Related]
8. The use of dextro-thyroxine (choloxin) in cardiovascular disease. Report of a clinical study. Reinhardt DJ Del Med J; 1968 Mar; 40(3):63-7. PubMed ID: 4868744 [No Abstract] [Full Text] [Related]
9. [Clinical expeiences with special indications for proscillaridine A in elderly and cirrhotic patients]. Strobbia R; Beggiato O; Manzoni A G Gerontol; 1967 Jul; 15(7):827-64. PubMed ID: 5606219 [No Abstract] [Full Text] [Related]
10. [Cardiac treatment of out-patients using encordin]. Schütz E Munch Med Wochenschr; 1969 Oct; 111(43):2239-43. PubMed ID: 5395247 [No Abstract] [Full Text] [Related]
12. [The use of a new cardioactive glucoside: Proscillaridin A, in the treatment of cardiopathy in the aged]. Massoni G G Gerontol; 1967 Apr; 15(4):565-72. PubMed ID: 5605011 [No Abstract] [Full Text] [Related]
13. [Clinical aspects of mathematical calculation of adequate therapeutic doses of pure cardiac glycosides]. Slutskiĭ ME Sov Med; 1967 Sep; 30(9):20-6. PubMed ID: 5604641 [No Abstract] [Full Text] [Related]
17. [Report on the clinical test of peruvoside]. Schwind K Med Welt; 1969 Jan; 3():134-42. PubMed ID: 5764799 [No Abstract] [Full Text] [Related]
18. [Pharmacology and therapeutic effects of a new semisynthetic cardioactive glycoside (P1)]. Königstein RP; Lindner A; Selzer H Wien Med Wochenschr; 1971 Jan; 121(4):53-6. PubMed ID: 5103273 [No Abstract] [Full Text] [Related]
19. [Clinical experience with a new cardiac glycoside]. Büsscher K Z Allgemeinmed; 1969 Feb; 45(6):265-8. PubMed ID: 5801646 [No Abstract] [Full Text] [Related]
20. [Clinical notes on the effect of a new cardiokinetic drug (proscillaridin A)]. Muzio L Minerva Med; 1966 May; 57(43 Suppl):2005-6. PubMed ID: 5944828 [No Abstract] [Full Text] [Related] [Next] [New Search]